Wei-Chih Shen

Title: Innovations by Wei-Chih Shen in Cancer Treatment

Introduction

Wei-Chih Shen is a notable inventor based in Taichung, Taiwan, recognized for his contributions to medical technology, particularly in cancer treatment. He has been instrumental in developing advanced systems that aid in predicting treatment responses for cancer patients. With a total of two patents to his name, Shen's work is at the forefront of integrating technology with healthcare.

Latest Patents

Wei-Chih Shen's latest patents include a computer-aided recognition system for treatment response of rectal cancer and a prediction system for tumor image-aided prognosis in patients with uterine cervical cancer. The first patent focuses on predicting the probability of a pathological complete response (pCR) in rectal cancer patients after preoperative neoadjuvant chemoradiotherapy. This system utilizes a random forest model composed of several decision trees, each with feature nodes that generate branches based on feature thresholds. The integration of these decision trees allows for a comprehensive final pCR probability. The second patent involves a prediction system that employs a data augmentation module and a deep convolution neural network model to analyze tumor images and predict patient prognosis following chemoradiotherapy.

Career Highlights

Wei-Chih Shen is affiliated with China Medical University Hospital, where he applies his expertise in medical technology to improve patient outcomes. His innovative approaches have garnered attention in the medical community, showcasing the potential of technology in enhancing cancer treatment methodologies.

Collaborations

Shen collaborates with esteemed colleagues, including Chia-Hung Kao and Shang-Wen Chen, to further advance research and development in the field of cancer treatment. Their combined efforts contribute to the ongoing evolution of medical technologies aimed at improving patient care.

Conclusion

Wei-Chih Shen's work exemplifies the intersection of technology and medicine, particularly in the realm of cancer treatment. His innovative patents reflect a commitment to enhancing patient outcomes through advanced predictive systems. The impact of his contributions is significant in the ongoing fight against cancer.